2017
DOI: 10.1038/s41698-017-0025-y
|View full text |Cite
|
Sign up to set email alerts
|

Live-single-cell phenotypic cancer biomarkers-future role in precision oncology?

Abstract: The promise of precision and personalized medicine is rooted in accurate, highly sensitive, and specific disease biomarkers. This is particularly true for cancer-a disease characterized by marked tumor heterogeneity and diverse molecular signatures. Although thousands of biomarkers have been described, only a very small number have been successfully translated into clinical use. Undoubtedly, there is need for rapid, quantitative, and more cost effective biomarkers for tumor diagnosis and prognosis, to allow fo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
23
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 26 publications
(23 citation statements)
references
References 88 publications
0
23
0
Order By: Relevance
“…Measures of cortical mechanical properties could serve as a minimally invasive technique to assess oocyte developmental potential for assisted reproductive technology, as already explored for tumors (for reviews, see refs. 53,54 ).…”
Section: Discussionmentioning
confidence: 99%
“…Measures of cortical mechanical properties could serve as a minimally invasive technique to assess oocyte developmental potential for assisted reproductive technology, as already explored for tumors (for reviews, see refs. 53,54 ).…”
Section: Discussionmentioning
confidence: 99%
“…Such heterogeneity, especially in the absence of specific molecular biomarkers, makes risk stratification, diagnosis, and selection of treatment regimens less accurate. 60 Rapid morphological classification of biopsied cancer cell populations in slide sections using DHM could provide a first-order evaluation of cancer heterogeneity, especially if morphology were linked to clinical behavior. Interestingly, intravital microscopy suggests that cancer cells undergo EM transition to enable metastasis but can rapidly revert to epithelial phenotypes once in the metastatic site, a process termed EM plasticity.…”
Section: Discussionmentioning
confidence: 99%
“…[1a,3] Different cellular subpopulations may exist in individual tumors and some of them have shown to be responsible for initiating cancer metastasis and accelerating cancer development. [3b,4] Additionally, during cancer progression and medication, the phenotypic status of CTCs could dynamically evolve . Therefore, it is of great importance to monitor the phenotypic distribution of CTCs at the resolution of individual cells rather than acquiring an average information, which could be more adaptable to predict disease progression and therapeutic efficiency.…”
Section: Introductionmentioning
confidence: 99%
“…Specifically, relying on only single biomarker to diagnose and assess cancer is not sufficiently specific due to the complex nature of cancer and its heterogeneity. Identifying one biomarker may achieve to distinguish cancerous cells from healthy samples but it is inadequate for differentiating the subtle variations among subtypes in one given cancer . To address this challenge, it is expected to develop a convenient technique which simultaneously measures a panel of phenotypic biomarkers for a comprehensive phenotype profile and more accurate subtype identification.…”
Section: Introductionmentioning
confidence: 99%